Eaton Vance Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-172
Closed -$8K 2992
2021
Q1
$8K Buy
+172
New +$6.39K ﹤0.01% 2426
2020
Q2
Sell
-80,000
Closed -$522K 1338
2020
Q1
$522K Sell
80,000
-40,000
-33% -$570K ﹤0.01% 1058
2019
Q4
$1.88M Hold
120,000
﹤0.01% 848
2019
Q3
$886K Hold
120,000
﹤0.01% 998
2019
Q2
$977K Hold
120,000
﹤0.01% 961
2019
Q1
$1.35M Hold
120,000
﹤0.01% 849
2018
Q4
$1.18M Buy
120,000
+65,000
+118% +$872K ﹤0.01% 837
2018
Q3
$908K Buy
+55,000
New +$878K ﹤0.01% 932

Other funds holding SGRY

Eaton Vance Management's SGRY Position: Q2 2021 in Review

Eaton Vance Management sold out of Surgery Partners (SGRY) in Q2 2021, closing a stake of 172 shares — an estimated $8K sold.

Eaton Vance Management first reported a position in SGRY in Q3 2018 and held it in 8 quarters. The position peaked at $1.88M in Q4 2019. 134 funds tracked by Wall St. Rank hold SGRY as of Q2 2021.

  • Eaton Vance Management reported no remaining Surgery Partners position as of Q2 2021 after selling out during the quarter.
  • Eaton Vance Management sold 172 Surgery Partners shares in Q2 2021, an estimated $8K.
  • Eaton Vance Management first reported a position in Surgery Partners in Q3 2018 and held it in 8 quarters.
  • Eaton Vance Management's Surgery Partners position peaked at $1.88M in Q4 2019.
  • 134 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2021.

Based on Eaton Vance Management's 13F filing for Q2 2021, filed 16 Aug 2021.